Gwen Lapham, PhD, MPH, MSW, recently published Prevalence of Cannabis Use Disorder and Reasons for Use Among Adults in a US State Where Recreational Cannabis Use Is Legal, in JAMA Network Open.
Dr. Lapham led the CTN-0077 study and is a PROUD (CTN-0074) co-investigator and Kaiser Permanente Washington Health Research Institute (KPWHRI) assistant investigator and addictions health services researcher. She is also an assistant affiliate professor in the Department of Health Systems and Population Health, University of Washington, and assistant professor in the Kaiser Permanente Bernard J. Tyson School of Medicine. Since joining KPWHRI, she has capitalized on her prior social work and health services training to do impactful research on evidence-based primary care for unhealthy substance use, including alcohol, cannabis, and opioids. She has recently begun making strides in understanding cannabis use among primary care patients, including medical use and use among prenatal women.
Kelly Young-Wolff, PhD, MPH was recently selected to be a member of the NASEM Committee to Review the Public Health Consequences of Changes in the Cannabis Policy Landscape. Dr. Young-Wolff is leading CTN-0140 and is a licensed clinical psychologist and research scientist at the Kaiser Permanente Northern California Division of Research. She is also an Adjunct Associate Professor in the Department of Psychiatry, University of California, San Francisco; Consulting Assistant Professor at the Stanford University School of Medicine; and Professor, Kaiser Permanente Bernard J. Tyson School of Medicine. Dr. Young-Wolff’s research focuses on substance use, focusing specifically on cannabis use among pregnant persons and adolescents and on the impact of changes in local, state, and national policy.
Posted on October 13, 2023